I-ne Co., Ltd. 2Q Earnings Preview

Rapid overseas growth and successive new haircare brand launches drive top-line expansion; profitability recovery during the investment-heavy phase is the key focus from 2Q onward

PublishedAugust 5, 2026 at 15:35 GMT+9

Summary

I-ne delivered consolidated revenue of JPY 12.493B (+12.4%) in 1Q, sustaining double-digit growth, while operating income came in at JPY 765M (▲13.8%), resulting in a top-line-growth/bottom-line-decline quarter driven by expanded strategic investments and JPY 109M in special investigation expenses. The primary debate for 2Q centers on whether the company can maintain its revenue growth trajectory and make progress on strategic investments. In addition, new haircare brands UNIPLEX (June) and Amprem (August) have been launched in quick succession, raising questions about whether the company's proprietary multi-brand strategy—anchored by its "brand creation capability" and "IPTOS" framework—can sustain gross profit margins alongside this expansion. Full-year operating income guidance spans an exceptionally wide range of JPY ▲500M to JPY 1,000M, making cumulative 1H results a critical inflection point that will determine the reliability of the full-year outlook.

Key Points for Next Quarter

Key Points & Focus	Implications
Revenue Growth SustainabilityCumulative 1H revenue progress vs. full-year guidance range (JPY 52B–54B)	1Q progress stood at 23.1–24.0%. Reaching 46–48% by 1H would bring the upper end of the guidance range into view, potentially catalyzing upward estimate revisions in the stock price
SG&A ControlSG&A ratio (SG&A/Revenue) YoY change	1Q came in at 53.7% (vs. 48.1% YoY), a +5.6pt deterioration. The balance between new brand investment spending and expected 2H payback will dictate the probability of achieving the full-year profit range
Gross Profit Margin StabilityQuarterly trajectory of consolidated gross margin	1Q improved to 59.8% (vs. 56.1% YoY), a +3.7pt gain. Whether this level can be sustained amid raw material cost and FX headwinds is a key assumption underpinning the profit plan
Governance & Trust RestorationWhether additional special investigation expenses are booked and progress on recurrence prevention measures	JPY 109M in special investigation expenses already booked in 1Q. The company's response to TSE's grace period designation will influence medium- to long-term capital market perception
New Brand Launch PerformanceRevenue trajectory for health food brands (Collatein, Teaflex, Befas)	The three health food brands achieved a combined monthly total exceeding JPY 300M in February. Confirming sustainability from 2Q onward will shape the market's assessment of portfolio diversification
Capital EfficiencyTrajectory of ROE and Net Debt/EBITDA	Equity ratio improved to 52.6% (vs. 49.8% at prior FY-end). With interest-bearing debt of JPY 6.32B, leverage management during this investment-heavy phase will define medium-term capital efficiency

Key Issues from Previous Results (FY12/2026 1Q)

1Q results showed +12.4% revenue growth, maintaining the growth pace, while operating income declined ▲13.8%, reflecting a phase where growth investments are being prioritized. Full-year operating income guidance is presented as a range of JPY ▲500M to JPY 1,000M—a JPY 1.5B spread—reflecting uncertainty around investment scale and payback timing. Below, we outline five key issues to monitor in the 2Q results.

1. Full-Scale Overseas Growth and Profitability

Prior Quarter:
Overseas revenue of JPY 587M (+225.7%), segment profit of JPY 135M (vs. JPY ▲62M in the year-ago period). Sales of BOTANIST launched at approximately 250 Costco stores in the US and YOLU at OLIVE YOUNG in South Korea in March
What to Watch This Quarter:
Revenue build from the full-quarter effect in April–June. Initial repurchase trends and inventory turnover in US channels, and quantitative assessment of J-Beauty demand in the Korean market
Key Metrics:
Quarterly trajectory of overseas segment revenue (growth rate from JPY 587M in 1Q), sustainability of segment margin (23.0% in 1Q)

2. SG&A Increase Composition and Investment Payback Path

Prior Quarter:
SG&A of JPY 6.71B (+25.4%), SG&A ratio of 53.7% (vs. 48.1% YoY). Corporate expenses rose to JPY 856M (vs. JPY 754M YoY, +13.5%)
What to Watch This Quarter:
Pace of advertising expense build-up associated with new brand launches including UNIPLEX (June) and Amprem (scheduled for August). As these investments are predicated on 2H payback, early signs of ROI at the 2Q stage are critical
Key Metrics:
QoQ change in SG&A ratio, advertising expenses as a percentage of revenue

3. Sustainability of Gross Margin Improvement and Cost Structure Shifts

Prior Quarter:
Gross profit margin of 59.8% (vs. 56.1% YoY, +3.7pt). COGS was JPY 5.016B (+2.9%), growing well below the +12.4% revenue growth rate
What to Watch This Quarter:
Whether FX volatility and raw material cost inflation driven by US trade policy begin to materialize in 2Q. Directional mix shifts as the overseas revenue contribution rises
Key Metrics:
Whether consolidated gross margin can hold in the 59% range, hedging position (deferred hedge gains/losses shifted by JPY ▲64M at 1Q-end)

4. Progress on Special Investigation Expenses and Governance Response

Prior Quarter:
JPY 109M in special investigation expenses booked, compressing pre-tax quarterly net income to JPY 597M (▲28.0%). This was the primary driver behind net income attributable to owners of parent company of JPY 173M (▲54.4%)
What to Watch This Quarter:
In June, the SESC recommended a surcharge payment order of JPY 6M, and the TSE announced a grace period for re-examination due to a pledge violation. Whether additional special losses are booked and costs related to internal control improvements
Key Metrics:
Whether additional special investigation expenses arise, disclosure status of improvement plans within the grace period

5. Effectiveness of the Multi-Brand Strategy and New Category Expansion

Prior Quarter:
Health food brands (Collatein, Teaflex, Befas) achieved a combined monthly total exceeding JPY 300M in February. GWHITE (oral care) began nationwide rollout at Loft stores. YOLU skincare line expanded distribution to drugstores
What to Watch This Quarter:
In haircare, UNIPLEX and Amprem have been added to the existing four brands (BOTANIST, YOLU, SALONIA, DROAS). With a growing brand count, progress on maintaining per-brand revenue scale and avoiding cannibalization is key
Key Metrics:
Domestic segment revenue YoY growth rate (1Q: +8.9%), shifts in revenue composition by category

Timely Disclosure & Industry Trends

2026/07/23
New Haircare Brand "Amprem" Launch Announced for August 28 - A new brand commercializing penetration technology from the company's proprietary JBIST research lab. Set for early launch via EC and Loft in August, followed by drugstore rollout from October, with advertising investment and revenue contribution expected to ramp from late 2Q through 3Q. New haircare brand "Amprem" launching August 28
2026/06/26
SESC Recommendation for Surcharge Payment Order - A surcharge payment order of JPY 6M was recommended in connection with corrections to prior-year annual securities reports. The financial impact is immaterial, but governance trust restoration will affect long-term corporate value. Notice Regarding SESC Recommendation for Surcharge Payment Order
2026/06/18
TSE Grace Period for Re-Examination Due to Pledge Violation and Penalty of JPY 33.6M - Maintaining the listing requires improvement within the grace period. Direct impact on business operations is limited, but restoring capital market confidence remains a challenge. Notice Regarding Grace Period for Re-Examination Due to Pledge Violation and Listing Agreement Penalty
2026/06/01
New Haircare Brand "UNIPLEX" Launching June 16 - A texture-improvement haircare line for coarse and thick hair, rolling out at Loft first then expanding to Tsuruha, Welcia, AEON, and others. A re-growth initiative for the haircare category. "UNIPLEX" launching June 16
2026/05/15
YOLU Cumulative Sales Surpass 100 Million Units - Achieved approximately four and a half years after the brand's launch in August 2021. Demonstrates strengthening market position of the flagship brand. YOLU cumulative brand sales surpass 100 million units

Previous Quarter Results (FY12/2026 1Q Actual)

I-ne is an asset-light manufacturer of beauty brands centered on BOTANIST, YOLU, and SALONIA, leveraging its competitive advantages in "brand creation capability," "OMO," and "IPTOS." Consolidated 1Q revenue reached JPY 12.493B (+12.4%), achieving double-digit growth driven by surging overseas operations (+225.7%) and solid domestic performance (+8.9%). However, operating income declined to JPY 765M (▲13.8%) due to new brand investment spending and higher corporate expenses. Combined with JPY 109M in special investigation expenses, net income attributable to owners of parent company was limited to JPY 173M (▲54.4%). Full-year guidance remains unchanged at revenue of JPY 52B–54B and operating income of JPY ▲500M–1,000M.

Item	Amount	YoY	vs. Company Plan	Remarks
Revenue	JPY 12.493B	+12.4%	-	Overseas +225.7%, Domestic +8.9%
Operating Income	JPY 765M	▲13.8%	-	Primarily driven by +5.6pt deterioration in SG&A ratio
Recurring Profit	JPY 706M	▲14.8%	-	JPY 47M in rental expenses newly booked
Net Income	JPY 173M	▲54.4%	-	JPY 109M in special investigation expenses booked
EPS	JPY 9.74	▲55.2%	-	-

Guidance Achievement Rate vs. Full-Year Plan (Our Estimate): Revenue 23.1–24.0% (vs. full-year range of JPY 52B–54B); operating income is difficult to evaluate on a simple progress basis as the full-year range of JPY ▲500M–1,000M includes a loss scenario

I-ne Co., Ltd.